文献速递小儿神经外科与脑积水神经肿瘤

立体定向内分流置入的微创第三脑室造瘘术治疗肿瘤相关非交通性脑积水

Minimally invasive third ventriculostomy with stereotactic internal shunt placement for the treatment of tumor-associated noncommunicating hydrocephalus.
PubMed 文献 · Acta Neurochir (Wien) · 2023-09-07

该单中心回顾性分析纳入2010年1月至2021年12月间因肿瘤导致梗阻性脑积水接受立体定向第三脑室造瘘联合内分流置入术(sTVIP)的38例患者,评估症状改善、并发症及免于翻修生存。结果显示74.2%患者症状改善,术前头痛是术后症状改善的显著预测因素(OR 26.25;95%CI 4.1-521.1;p=0.0036),无症状出血2例(5.3%),无手术相关死亡,37例在中位12个月随访期内维持分流独立。

要点

  • sTVIP术后74.2%的患者症状改善,术前头痛是术后症状改善的显著预测因素(OR 26.25;95%CI 4.1-521.1;p=0.0036)。
  • 无症状性出血沿立体定向轨迹检出2例(5.3%),1例因脑脊液瘘需局部翻修(2.6%),另1例因脑脊液吸收不良需二次手术连接导管至阀门/腹腔导管。
  • 中位随访12个月(IQR 3-32个月)期间,37例患者维持分流独立,无手术相关死亡。

核心结论

  • sTVIP可显著控制症状,手术并发症发生率低,随访期内维持分流独立的比例高;因此sTVIP是肿瘤相关梗阻性脑积水的一种高效、微创的治疗选择,即使在前桥池狭窄的病例中也是如此。

研究设计与样本

  • 单中心、回顾性分析,评估2010年1月至2021年12月期间因肿瘤导致梗阻性脑积水接受sTVIP治疗的所有患者的临床症状、手术相关并发症及免于翻修生存。
  • 共分析38例患者(女性11例,男性27例)的临床记录,平均年龄40岁(范围5-88岁)。

主要发现

  • 梗阻性脑积水主要由原发性脑肿瘤引起(占92%的患者),例外为3例转移瘤。
  • sTVIP术后74.2%的患者症状改善;术前头痛是术后症状改善的显著预测因素(OR 26.25;95%CI 4.1-521.1;p=0.0036)。
  • 沿立体定向轨迹检出无症状性出血2例(5.3%);1例患者因脑脊液瘘需局部翻修(2.6%);另1例患者因脑脊液吸收不良需二次手术将导管连接至阀门/腹腔导管。
  • 其余37例患者在中位随访12个月(IQR 3-32个月)期间维持分流独立;未观察到手术相关死亡。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intracranial tumors can cause obstructive hydrocephalus (OH). Most often, symptomatic treatment is pursued through ventriculoperitoneal shunt (VS) or endoscopic third ventriculostomy (ETV). In this study, we propose stereotactic third ventriculostomy with internal shunt placement (sTVIP) as an alternative treatment option and assess its safety and efficacy. METHODS: In this single-center, retrospective analysis, clinical symptoms, procedure-related complications, and revision-free survival of all patients with OH due to tumor formations treated by sTVIP between January 2010 and December 2021 were evaluated. RESULTS: Clinical records of thirty-eight patients (11 female, 27 male) with a mean age of 40 years (range 5-88) were analyzed. OH was predominantly (in 92% of patients) caused by primary brain tumors (with exception of 3 cases with metastases). Following sTVIP, 74.2% of patients experienced symptomatic improvement. Preoperative headache was a significant predictor of postoperative symptomatic improvement (OR 26.25; 95% CI 4.1-521.1; p = 0.0036). Asymptomatic hemorrhage was detected along the stereotactic trajectory in 2 cases (5.3%). One patient required local revision due to CSF fistula (2.6%); another patient had to undergo secondary surgery to connect the catheter to a valve/abdominal catheter due to CSF malabsorption. However, in the remaining 37 patients, shunt independence was maintained during a median follow-up period of 12 months (IQR 3-32 months). No surgery-related mortality was observed. CONCLUSIONS: sTVIP led to a significant symptom control and was associated with low operative morbidity, along with a high rate of ventriculoperitoneal shunt independency during the follow-up period. Therefore, sTVIP constitutes a highly effective and minimally invasive treatment option for tumor-associated obstructive hydrocephalus, even in cases with a narrow prepontine interval.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Niedermeyer S, Terpolilli NA, Nerlinger P, et al. Minimally invasive third ventriculostomy with stereotactic internal shunt placement for the treatment of tumor-associated noncommunicating hydrocephalus. Acta Neurochir (Wien). 2023. PMID: 37676505. doi:10.1007/s00701-023-05768-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。